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Abstract
Objectives: The purpose of this study was to compare cardiovascular magnetic resonance (CMR)
and echocardiography (echo) in patients treated with primary percutaneous coronary intervention
(PCI) for acute myocardial infarction (AMI) with emphasis on the analysis of left ventricular function
and left ventricular wall motion characteristics.
Methods: We performed CMR and echo in 52 patients with first AMI shortly after primary
angioplasty and four months thereafter. CMR included cine-MR and T1-weighted first-pass and late-
gadolinium enhancement (LGE) sequences. Global ejection fraction (EFCMR, %) and regional left
ventricular function (systolic wall thickening %, [SWT]) were determined from cine-MR images. In
echo the global left ventricular function (EFecho, %) and regional wall motion abnormalities were
determined. A segment in echo was scored as "infarcted" if it was visually > 50% hypokinetic.
Results: EFecho revealed a poor significant agreement with EFCMR at baseline (r: 0.326; p < 0.01) but
higher correlation at follow-up (r: 0.479; p < 0.001). The number of infarcted segments in
echocardiography correlated best with the number of segments which showed systolic wall
thickening < 30% (r: 0.498; p < 0.001) at baseline and (r: 0.474; p < 0.001) at follow-up.
Improvement of EF was detected in both CMR and echocardiography increasing from 44.2 ± 11.6%
to 49.2 ± 11% (p < 0.001) by CMR and from 51.2 ± 8.1% to 54.5 ± 8.3% (p < 0.001) by
echocardiography.
Conclusion: Wall motion and EF by CMR and echocardiography correlate poorly in the acute
stage of myocardial infarction. Correlation improves after four months. Systolic wall thickening by
CMR < 30% indicates an infarcted segment with influence on the left ventricular function.
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Background
Ischemic heart disease has become the leading cause of
death from cardiovascular disease worldwide [1]. There-
fore the diagnosis of myocardial infarction, early treat-
ment through primary angioplasty and the evaluation of
regional cardiac function by means of cardiac imaging are
of increasing importance. The most important clinical
application of regional functional analysis is the assess-
ment of reversibly injured but still viable myocardium in
ischemic heart disease [2,3]. Cardiovascular magnetic res-
onance (CMR) detects myocardial stunning from wall
motion abnormalities. Gadolinium based contrast agents
are used to assess myocardial perfusion, to identify nonvi-
able myocardium and scarring, and to estimate the extent
of infarction [4,5] ensuring minimal interobserver and
intraobserver variability [6]. The exact measurement of
infarct size may provide valuable information on ven-
tricular remodelling, arrhythmic potential, and prognosis
and is a commonly used surrogate endpoint for the eval-
uation of new therapies for acute myocardial infarction
(AMI) [7]. Several studies reported an "overestimation" of
infarct size based on contractile function in acute myocar-
dial infarction [8], mostly due to viable tissue surround-
ing the infarct [9-12]. Mahrholdt et al [13] described an
"inverse tethering", an underestimation of infarct size, in
chronic myocardial infarction due to contraction of
neighbouring segments. This inevitably leads to difficult
interpretation of data concerning early and late infarct size
as well as left ventricular wall characteristics [14]. How-
ever, the clinical assessment of regional function – in par-
ticular, of myocardial viability and stress-induced
ischemia – is based on the subjective assessment of wall
motion [15]. Although the quantitative measurement of
wall thickening provides a more precise parameter of
regional function than visual estimation of wall motion
by echocardiography (echo) [8], the latter is the most
commonly used tool to assess cardiac morphology and
function in daily clinical practice [16].
Few studies have directly compared echo with CMR in
patients with AMI [16,17] – a comparison that forms a
basis for the interpretation of functional results using dif-
ferent imaging modalities [18]. In the following study we
compared these two cardiac imaging modalities by using
the AHA 17-segment model in patients with first AMI
shortly after primary percutaneous coronary intervention
(PCI) and four months thereafter. Our three main focal
points are on the evaluation of left ventricular function,
the evaluation of left ventricular wall motion characteris-
tics and its improvement within a follow-up period of 4
months.
Methods
Patient population
Fifty-two patients (44 men and 8 women) admitted to the
coronary care unit (CCU) at the Innsbruck University
Hospital, presenting with first AMI defined by elevated
cardiac enzymes and an ECG with ST-segment elevation ≥
2 mm in 2 continuous electrocardiographic leads, were
eligible for enrolment. Patients were included if they had
a) no previous history of myocardial infarction b) a
"Thrombolysis in Myocardial Infarction" (TIMI) flow of
less than 3 prior to p-PCI) c) a TIMI flow of 3 after percu-
taneous revascularisation in the affected coronary artery
and had no contraindications to CMR.
The study protocol was approved by the hospital ethics
committee, and informed consent was obtained from
each patient.
CMR and echocardiographic investigations were per-
formed in all patients shortly after (3 ± 2 days) p-PCI and
approximately four months after reperfusion (131 ± 45
days).
Mean delay, defined as "onset of pain-to-balloon" time,
was 4.6 ± 5 hours, ranging from 0.5 to 24 hours. All
patients were treated with p-PCI and six received throm-
bolysis prior to mechanical revascularisation. Seven
patients had to be excluded because of a delay lasting
longer than 24 hours. Three patients had to be excluded
because of claustrophobia during CMR, and in two CMR
scans, no gadolinium was given. Those patients were
excluded from the study prior to statistical analysis. Table
1 summarises the clinical characteristics of the patient
population.
CMR protocol
Using a 1.5 Tesla MR scanner (Magnetom Avanto, Sie-
mens, Erlangen, Germany) providing total imaging
matrix, cine-MR images in short- and long-axis were
acquired during breath-hold, with retrospective ECG-trig-
gered trueFISP (Fast Imaging with Steady-State Preces-
sion) bright-blood sequences with generalized
autocalibrating partial parallel acquisition (GRAPPA,
acceleration factor: 2) reconstruction. The patients were
positioned into the spine array coil and covered by an 8-
channel array coil, resulting in a total of 16 array elements
for signal collection. Since it is known that signal acquisi-
tion with the help of multiple receiver coil systems can be
deranged by the non-uniformity of coil sensitivities [19],
we employed the prescan normalization function for
intensity inhomogeneity correction.
The short-axis sequence contained 11 slices and had a rep-
etition time (TR) of 46.8 ms, an echo time (TE) of 1.1 ms,
a slice thickness (SL) of 8 mm, a field of view (FoV) of 350
× 263 mm, a matrix of 320 × 260, and a flip angle (FA) of
71°. The long-axis sequence contained 3 slices with a TR
of 54.5 ms, a TE of 1.28 ms, a SL of 6 mm, a FoV of 360 ×
293 mm, a matrix of 320 × 260, and a FA of 71°.Journal of Cardiovascular Magnetic Resonance 2009, 11:22 http://www.jcmr-online.com/content/11/1/22
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Each patient underwent dynamic bolus tracking with the
help of an ECG-triggered single-shot trueFISP and a Gado-
linium bolus of 0.1 mmol/kg body weight (Gd-DTPA,
Magnevist, Schering, Berlin). The contrast bolus was
injected into the cubital vein with a flow rate of 5 mL/s by
using a commercially available MR injector (Spectris,
Medrad, Pittsburgh, PA).
The dynamic trueFISP had a FoV of 380 × 265 mm, a SL
of 8 mm, a matrix of 128 × 96, a TR of 172 ms, a TE of 0.96
ms and a GRAPPA iPat factor of 2.
After a minimum of 10 min. and an additional contrast
bolus (another 0.1 mmol/kg body weight) was applied.
Late Gadolinium Enhancement (LGE) CMR was per-
formed on the same scanner by using a phase-sensitive
inversion recovery single-shot balanced steady-state free
precession sequence with consecutive slices perpendicular
to the short axis with a TR of 590 ms, a TE of 1.2 ms, a SL
of 8 mm, an inter-slice gap of 2 mm, a FoV of 400 × 363
mm, a matrix of 256 × 232, a FA of 45°, and a GRAPPA
iPat factor of 2.
Post-processing of CMR
Planimetry of LGE images was performed off-line using a
commercially available software tool (J-Vision Vs. 3.3.16,
TIANI). A threshold of +5 SD above the signal intensity of
normal myocardium in the opposite non-infarcted myo-
cardial segment was set to define the extent of LGE. Infarct
volume [cm3] was calculated by multiplying the LGE area
with slice thickness including the inter-slice gap.
Volumetric evaluation was performed using standard soft-
ware (ARGUS, Siemens Erlangen, Germany). Contouring
of left ventricular endo- and epicardial borders was per-
formed semi-automatically. Left ventricular myocardial
mass was calculated by multiplying the wall volume and
the specific density of cardiac muscle (1.05 g/cm3).
Myocardial systolic segmental wall thickening (SWT)
analysis was performed for each slice on the basis of the
same endo- and epicardial contours. For each segment,
end-diastolic and end-systolic wall thickness (EDWT,
ESWT [mm]) as well as end-diastolic to end-systolic wall
thickening (SWT, [mm] or [% of EDWT]) were assessed
and calculated. SWT was summed and then averaged for
each segment from the short axis slices involved by this
segment. All segments were divided into groups according
to their SWT, resulting in 5 groups with SWT of 20, 30, 40,
50 and 60%. Subsequently, these groups were correlated
to infarcted segments in echocardiography, segments
showing late enhancement, infarct mass in grams and
EFCMR and EFecho. See Table 2.
Echocardiography
For transthoracic echocardiography a Sequoia 256 ultra-
sound unit (Acuson-Siemens Inc., Mountain View, Cali-
fornia) was employed. Measurements of end-diastolic
volume (EDV), end-systolic volume (ESV) and ejection
fraction (EF, %) were done using standard software. The
apical 5-chamber and 3-chamber views were used to cal-
culate end-diastolic and end-systolic volumes according
to the apical biplane summation-of-disks algorithm
according to the guidelines by the American Society of
Table 1: Clinical parameters
Study variable Values, mean ± SE
Age (yrs) 54 ± 12
Patients (number) 52
Men (number) 44
Body mass index (kg/m2) 25.1 ± 2.8
Days between AMI to baseline scan
2D 3.4 ± 1.7
CMR 2.8 ± 1.6
Days between baseline and follow-up imaging
2D 131 ± 45
CMR 132 ± 45
Delay, (h) 4.6 ± 5
cTnT, ug/l (max) 6.43 ± 4.26
CK, U/l (max) 2172 ± 1468
Infarct localisation
posterior wall 31
anterior wall 18
lateral 3
Pre-hospital thrombolysis 6
2D findings
EF (%), baseline 51.2 ± 8.1
EF (%), follow-up 54.5 ± 8.3
Segments evaluated 832
"infarcted" segments, baseline 2.1 ± 1.6
"infarcted" segments, follow-up 1 ± 1
CMR findings
EF (%), baseline 44.2 ± 11.6
EF (%), follow-up 49.2 ± 11.1
Infarct mass (g), baseline 19.5 ± 12.2
Infarct mass (g), follow-up 15.8 ± 11.1
Segments showing LGE, baseline 7.4 ± 3.1
Segments showing LGE, follow-up 7.3 ± 3
Clinical characteristics of study patients; AMI: acute myocardial 
infarction, 2D: 2 dimensional echocardiography, CMR: cardiac 
magnetic resonance, Delay: door-to-balloon-time, cTnT: cardiac 
Troponin T, CK: creatine kinase, EF: ejection fraction, LGE: late 
enhancement. Data is presented as mean ± standard error (SE)Journal of Cardiovascular Magnetic Resonance 2009, 11:22 http://www.jcmr-online.com/content/11/1/22
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Echocardiography using an average of two or three beats
[20].
In the visual assessment of regional wall motion abnor-
malities, a segment was scored as infarcted if it was visu-
ally > 50% hypokinetic. The decision to use 50% as a cut-
off value to define an infarcted segment in echocardiogra-
phy was made by the authors out of practical reasons to
achieve a higher accuracy of this visually based method.
The visual assessment of wall motion abnormalities as
well as the assessment of the EF were done by one highly
experienced echocardiographer.
Segmental model
All images (echocardiography and CMR) were analysed
using the American Heart Association/American College
of Cardiology (AHA/ACC) recommended 17-segment
model [21] to provide adequate sampling of the left ven-
tricle and coronary distribution without exceeding the res-
olution limits of the imaging modalities. Segment 17, the
apex, was not analysed due to poor image quality of this
part of the heart. In CMR two to three short axis images
were assigned to either basal, mid or apical segments vis-
ually according to anatomic landmarks (papillary mus-
cles) and 4-chamber view. In echocardiography standard
cut planes were used to assess wall motion abnormalities
and a moving grid representing the 17-segment model
was placed in a certain position assigning segment 2 and
3 to the septum.
Statistics
Analysis was performed with SPSS 16.0 for Windows
(SPSS Inc., Chicago, IL). Normality was tested by Kol-
mogorov-Smirnov test. Pearson (if normally distributed
(ND) and Spearman test (if not ND) were used for calcu-
lation of linear correlations for selected variables. With
regard to the correlation of segments, paired Wilcoxon
rank test was used to determine statistical significance of
segmental improvement between baseline and follow-up.
ANOVA with Bonferroni post-hoc testing (if normally dis-
tributed, ND) and Kruskal-Wallis test (K-W, if not ND)
were used to determine differences between groups. A
probability value of p < 0.05 was considered significant.
Data is presented as mean ± standard error (SE) if not
stated otherwise. Sensitivity and specificity were assessed
by cross tabulation.
Results
Correlation of ejection fraction assessed by echo and CMR
EF in echocardiography (EFecho) correlated poorly with EF
in magnetic resonance imaging (EFCMR) at baseline (r:
0.326; p < 0.01) but better at follow-up (r: 0.479; p <
0.001). (Figure 1). Comparison of EFecho (baseline: 51.2 ±
8.1%, follow-up: 54.5 ± 8.3%; p < 0.01) with EFCMR (base-
line: 44.2 ± 11.6%, follow-up: 49.2 ± 11%) revealed that
echo measured statistically significantly higher global EF
than cine-CMR at baseline and at follow-up (p < 0.001).
Wall motion abnormalities assessed visually by echo and 
semi-automatically by CMR
A comparison of wall motion abnormalities assessed by
the two different imaging techniques revealed the follow-
ing results. Systolic wall thickening in CMR, semi-auto-
matically assessed, correlates in all values highly
significant with the visually assessed wall motion abnor-
malities in echo. In echo a segment was scored as infarcted
if it was > 50% hypokinetic. The best correlation between
SWT in CMR and infarcted segments in echo could be
detected at a SWT value less than 30% (r: 0.498; p <
0.001) Table 2 shows the individual values for the ana-
lysed segments.
Correlation of SWT scores
SWT < 30% in CMR showed a highly significant correla-
tion (p < 0.001) with EFecho and EFCMR (r: 0.449 and r:
0.744, respectively) and the infarct mass in grams (r:
0.591) at baseline and at follow-up (r: 0.382, r: 0.561 and
r: 0.545, respectively.) Table 2.
Table 2: Correlation of SWT scores with CMR findings and infarcted segments in echo
Baseline Follow-up
SWT Number of infarcted 
segments
in echo
EF
Echo
EF
CMR
Infarct mass in 
grams
Number of infarcted 
segments
in echo
EF
Echo
EF
CMR
Infarct mass in 
grams
< 20% 0.446 0.434 0.714 0.604 0.380 0.360 0.505 0.440
< 30% 0.498 0.449 0.744 0.591 0.474 0.382 0.561 0.545
< 40% 0.406 0.377 0.742 0.525 0.488 0.431 0.584 0.544
< 50% 0.316 0.364 0.762 0.475 0.533 0.448 0.597 0.513
< 60% n.s. 0.386 0.737 0.369 0.555 0.470 0.633 0.500
Table 2 shows the correlation of different SWT (systolic wall thickening) scores, markers of regional wall motion abnormality, with the number of 
infarcted segments in echo (assessed visually, > 50% hypokinetic), late enhancement in CMR and EF in echo and CMR, in all values (p < 0.001). The 
best correlation of infarcted segments in echo and SWT in CMR is found at a SWT less then 30%. SWT < 30% correlates also highly significant with 
EFCMR and EFecho. Through this correlation we were able to describe a cut-off value of less than 30% SWT to define an infarcted segment in CMR 
with influence on the left ventricular function. Spearman test was used for linear correlations of the selected variables. n.s = not significant.Journal of Cardiovascular Magnetic Resonance 2009, 11:22 http://www.jcmr-online.com/content/11/1/22
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A cross tabulation of segments showing LGE with differ-
ent SWT scores revealed the following sensitivities for
baseline: SWT < 20% (sensitivity 20.9%), SWT < 30%
(33.9%), SWT < 40% (45.2%), SWT < 50% (56.6%), SWT
< 60% (63.8%) and at follow-up: SWT < 20% (sensitivity
17.4%), SWT < 30% (27.4%), SWT < 40% (37.5%), SWT
< 50% (49.3%), SWT < 60% (58.3%). See Table 3.
Transmurality and SWT
Mean SWT for non affected segments at baseline was
63,6% ± 20.3%. 448 segments showed no transmurality
(group 1), 59 had a transmurality less than 50% (group 2)
and 325 showed a transmurality over 50% (group 3). In
order to detect differences between the transmural extent
of the infarct and change of SWT, we made three groups
according to their transmurality. In the acute state of myo-
cardial infarction we detected a highly significant differ-
ence in SWT between the first group and the third group.
Within the groups there could not be detected any differ-
ence regarding SWT and transmurality and there was no
detectable difference between group 1 and group 2. Table
4
Improvement of left ventricular wall characteristics four 
months post AMI
Of the 832 evaluated segments (52 patients × 16 seg-
ments), improvement of the following parameters was
highly significant (p < 0.001) after a four-month period.
The total number of infarcted segments in echo decreased
from 111 to 57. At baseline the mean EFecho was 51.2 ±
8.1% and 54.5 ± 8.3% at follow-up (p < 0.001). The mean
EFCMR increased from 44.2 ± 11.6% to 49.2 ± 11% (Figure
Correlation of EFecho and EFCMR at baseline and at 4-month follow-up Figure 1
Correlation of EFecho and EFCMR at baseline and at 4-month follow-up. Figure 1 shows the correlation of EF (ejection 
fraction) between echo and CMR at baseline (dashed line, r: 0.326; p < 0.01) and at follow-up (continuous line, r: 0.479; p < 
0.001). At follow-up echocardiography correlates better with CMR than at baseline.Journal of Cardiovascular Magnetic Resonance 2009, 11:22 http://www.jcmr-online.com/content/11/1/22
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Table 3: Cross tabulation of various SWT scores with segments showing LGE in CMR
Baseline Follow-up
LGE negative LGE positive LGE negative LGE positive
SWT < 20% negative 382 306 SWT < 20% negative 381 313
positive 63 81 positive 72 66
sensitivity 20.9 sensitivity 17.4
specificity 85.8 specificity 84.1
SWT < 30% negative 342 256 SWT < 30% negative 361 275
positive 103 131 positive 92 104
sensitivity 33.9 sensitivity 27.4
specificity 76.9 specificity 79.7
SWT < 40% negative 304 212 SWT < 40% negative 324 237
positive 141 175 positive 129 142
sensitivity 45.2 sensitivity 37.5
specificity 68.3 specificity 71.5
SWT < 50% negative 252 168 SWT < 50% negative 283 192
positive 193 219 positive 170 187
sensitivity 56.6 sensitivity 49.3
specificity 56.6 specificity 62.5
SWT < 60% negative 206 140 SWT < 60% negative 239 158
positive 239 247 positive 214 221
sensitivity 63.8 sensitivity 58.3
specificity 46.3 specificity 52.8
Table 3 compares each SWT (systolic wall thickening) score at baseline and follow-up through cross tabulation with the segments in CMR showing 
LGE (late enhancement). Sensitivity and specificity were calculated through cross tabulation.
Table 4: Transmurality and SWT
Transmurality Number of segments Mean SWT ± SE Statistical difference to group 2 
(< 50%)
Statistical difference to group 3 
(> 50%)
group 1: 0 448 63.6% ± 20.4% n.s. p < 0.001
group 2: < 50% 59 50.44% ± 48.7% x n.s.
group 3: > 50% 325 50.08% ± 20.0% n.s. x
In order to detect differences between the transmural extent of the infarct and changes of SWT (systolic wall thickening), we made three groups 
according to their transmurality (first had no transmurality, second had less than 50%, and the third had more than 50% transmurality). In the acute 
state of myocardial infarction we detected a highly significant difference in SWT between the first group with no scar and group 3 (p < 0.001). 
Within the groups there could not be detected any difference regarding SWT and transmurality. There could not be detected any difference 
between group 1 and group 2. n.s. = not significant, SE = standard error. ANOVA with Bonferroni post-hoc testing was used for statistical analysis.Journal of Cardiovascular Magnetic Resonance 2009, 11:22 http://www.jcmr-online.com/content/11/1/22
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2). The infarct mass in grams decreased from 19.5 ± 12.2
grams at baseline to 15.8 ± 11.1 grams at follow-up.
Discussion
Correlation of ejection fraction
In this study left ventricular function was measured both
by echocardiography and CMR in the same patient popu-
lation shortly after primary PCI in the setting of AMI and
at four months follow-up.
A comparison of the two imaging modalities regarding
ejection fraction revealed a poor correlation both at base-
line and follow-up, with the agreement being better at fol-
low-up (Figure 1). The difference between acute and
follow-up correlations might be due to two conditions. In
acute infarction, contractile function may be reduced due
to myocardial stunning and accessorily by non-reperfused
infarction due to ongoing ischemia despite adequate
mechanical revascularisation as hypothesised by
Marholdt et al. [13]. Since stunned myocardium – the
result of an ischemic insult leading to contractile dysfunc-
tion [22] – resolves on a time scale of days to weeks [13],
it can be expected to have no influence on contractile
function at our 4-month follow-up investigation. Ongo-
ing ischemia could be excluded as well, as we only
enrolled patients with post-procedural TIMI-flow 3, i.e.,
those with successful revascularisation.
Furthermore, acute changes occurring in left ventricular
loading conditions due to emergency medication or intra-
Improvement of EFecho and EFCMR at 4-month follow-up Figure 2
Improvement of EFecho and EFCMR at 4-month follow-up. Figure 2 shows the EF (ejection fraction) for echocardiogra-
phy (51.2 ± 8.1%) and CMR (44.2 ± 11.6%, at baseline (EF echo 1, EF CMR 1) and follow-up (EF echo 2, EF CMR 2) (54.5 ± 
8.3%, and 49.2 ± 11%, respectively) and visualises the statistically highly significant (p < 0.001) improvement at 4-month follow-
up. (* p < 0.001, + p < 0.01). Data is presented as mean ± standard error and median.Journal of Cardiovascular Magnetic Resonance 2009, 11:22 http://www.jcmr-online.com/content/11/1/22
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venous fluid administration are absent in the chronic sce-
nario, which might also explain the differences in the EF
readings obtained by both imaging modalities between
acute and chronic conditions.
While interpreting the higher correlation in the chronic
state of myocardial infarction it should be mentioned that
31 of the 52 patients presenting to the CCU with acute
coronary syndrome had a posterior wall infarction. Since
in biplane echocardiographic EF analyses contractility of
the posterior wall may not fully account for EF, a slight
overestimation in the calculation of the EF may result and
might explain the higher echocardiographic EF values.
This presumption is reinforced by a subanalysis showing
a statistically highly significant difference (p < 0.001)
between EFecho (54.1% at baseline and 55% at follow-up)
and EFCMR (45.3% at baseline and 49.3% at follow up) in
patients with posterior wall infarction. This difference was
not detected in anterior wall or lateral infarction (no sig-
nificant difference). CMR, with its capability for volumet-
ric evaluation, is able to view the whole left ventricle and
detect wall motion abnormalities even in regions inacces-
sible to echo and it is less likely operator dependent than
biplane echo.
Ventricular and contractile function improvement has
been reported to occur as a result of successful reperfusion
[23-27]. Such improvement might be the reason for our
observation that echo was a more accurate diagnostic
instrument at follow-up (Figure 2) because of the previ-
ously mentioned omittance of the posterior wall in echo.
After contractile improvement of the posterior wall this
part of the heart might make a greater contribution to the
EF, and therefore the correlation with CMR is more accu-
rate.
Reichek et al. [28] presented preliminary results and deter-
mined LVEF in 28 patients after AMI by volumetric CMR
and biplane echo, revealing a correlation of r: 0.43, which
is similar to our results (baseline correlation r: 0.339; p <
0.001). Jenkins et al. [17] compared 2D, 3D and CMR in
patients with healed myocardial infarction and found a
high correlation between EFecho and EFCMR at 1 year fol-
low-up of r: 0.70; p < 0.01. Thus, our findings on the
higher grade of accuracy of echo under conditions of
chronic myocardial infarction are in agreement with those
reported in literature.
Another point that has to be taken into account is that
echo revealed statistically significant higher EF values at
baseline and at follow-up. This would imply an underes-
timation of infarct size in both settings, acute and chronic.
This is an important fact that may influence clinical act-
ing, as the EF is the most common consulted value to
define left ventricular function, and has been proven to be
an important indicator of prognosis after acute myocar-
dial infarction [29-31].
Systolic wall thickening in CMR
Animal studies have found that, independent of wall
motion or infarct age, the size and the shape of regions
showing late enhancement coincide with regions of myo-
cardial necrosis and irreversible injury; regions, however,
with a lack of LGE are viable [32,33]. Further studies
showed that late enhancement detected within 24 hours
after primary PCI in the infarct zone is an independent
predictor of impaired left ventricular systolic thickening
and remodelling [34,35].
In Table 3. we assessed a segment showing late enhance-
ment as the gold standard to define an infarcted segment
in CMR and compared it to different SWT scores. Through
cross tabulation we could detect a relatively low, but
increasing sensitivity the higher we set the SWT cut-off
value. This shows that an infarcted segment, demon-
strated through late enhancement, is always associated
with a slight wall motion abnormality and therefore has a
certain influence on the contractile function of the left
ventricle. The crux is that not every wall motion abnor-
mality leads to impaired left ventricular function and fur-
thermore to a clinical deterioration. A SWT cut-off value
had to be found in CMR that characterises a severely
injured myocardial segment shortly after p-PCI ("inf-
arcted" segment) with wide influence on the clinical out-
come and bearing on the global ventricular function.
No prior study has defined the exact degree of reduction
in SWT in CMR needed to be interpreted as "infarcted".
Therefore, we attempted to find this degree of SWT reduc-
tion by correlating different SWT scores with the number
of affected segments in echo, the infarct mass in grams
and the ejection fraction (measured both with echo and
CMR). The best correlation of infarcted segments in echo
and SWT in CMR was found at a SWT less then 30%. SWT
less than 30% also correlated also highly significant with
EFCMR and EFecho. Through this correlation we were able to
describe a cut-off value in CMR of less than 30% SWT to
define an infarcted segment which has a bearing on the
clinical outcome. Table 2. Furthermore we detected that
the average SWT for healthy segments was 63.6%, so our
cut-off value of 30% represents a 50% restriction of a nor-
mal SWT. This cut-off value has a specificity of 76.9% and
a sensitivity of 33.9% and for us this value has a higher
priority than the cut-off value analysed through ROC
curves, which would be a SWT of 60% (with a sensitivity
of 63.8% and a specificity of 46.3%).
Transmurality and SWT in CMR
Choi et al. [27] reported that in patients with acute myo-
cardial infarction, the transmural extent of infarctionJournal of Cardiovascular Magnetic Resonance 2009, 11:22 http://www.jcmr-online.com/content/11/1/22
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defined by CMR predicts improvement in contractile
function. We found a highly significant difference in SWT
between segments with no late enhancement and seg-
ments with a transmurality of more than 50%. Interest-
ingly we could not detect any changes of SWT within the
two groups with transmurality and between the first group
with no transmurality and the second group with less than
50% transmurality. This might be due to the fact that con-
tractile function in acute myocardial infarction is reduced
because of myocardial stunning. Table 4.
Limitations
Otterstad et al. reported that the coefficient of variation of
EFecho is 15%, with 12% of this ascribable to test-retest var-
iability [36]. In order to keep this inaccuracy as low as pos-
sible, all echocardiographic measurements in our study,
baseline and follow-up, were done by one experienced
observer.
Secondly, because of relatively short delays – 19 patients
had a delay of less than 3 hours, 24 were within a range of
3 to 6 hours, 7 patients were within a range of 6 to 12
hours and 2 patients had a delay longer than 12 hours –
the infarcted mass could be kept relatively small, as previ-
ously reported by our research group [14]. Myocardium
showing only slight impairment or in some cases even no
impairment (16 patients had an EF > 55%), may have
been difficult to detect by echo. The correlation between
echo and CMR may have been even more significant in
more severely injured myocardium.
In summary, the results of our study show that CMR
might be the more accurate method for assessing left ven-
tricular function in the acute phase of myocardial infarc-
tion, whereas in the chronic state, also echocardiography
can be a valuable and accurate instrument. Furthermore,
systolic wall motion thickening in CMR at less than 30%
can be used as a cut-off value to define an infarcted seg-
ment with influence on the left ventricular function.
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